71-year-old Zhao Xuemin four years ago was diagnosed with stomach cancer and gastric cancer has a penetration. Tianjin Tumor Hospital for gastric cancer had a radical surgery, the activated carbon adsorption in the anti-cancer drug mitomycin into his abdominal cavity. Anti-cancer drug effective in controlling the transfer of cancer cells, but very little side effects. To the current Zhao Xuemin still alive and healthy.
Gastric cancer is a serious hazard to human health one of the cancer, gastric cancer incidence rate of 16.23 / 100,000. Due to various reasons, of the patients admitted to advanced-based, treatment by radical resection, of supporting the implementation of conventional chemotherapy. However, due to drugs around the body and reduce the efficacy and side effects great, so the final two-thirds of the patients in local or regional recurrence, the five-year survival rate is only around 20 percent.
Tianjin Tumor Hospital by Liang Han, director of gastrointestinal doctor, who five years ago began a carbon adsorption MMC abdominal chemotherapy, the clinical study. They cleverly use of the activated carbon adsorption of the physical, first of all, the activated carbon adsorption large doses of anti-cancer drug mitomycin. Absorption of carbon have anti-cancer drugs as a foreign body rapidly around the remnant stomach lymphoid tissue absorption, concentrated in the lymph , and slowly released directly into the peritoneal fluid , Portal and liver in a 24-hour sustained high concentrations of anti-cancer drugs, so that the free cultivation of gastric cancer in the peritoneal cancer cells and the remnants of the tiny tumors directly immersed in the high concentration of anti-cancer Drugs, to kill cancer cells. Those operations have been found in violation of stomach cancer in patients with serous, after the completion of radical surgery, will be a super-massive absorption of carbon stored in MMC abdominal cavity, the eradication of a sub-clinical stage of the cancer cells.
Take advantage of this method of treatment of advanced gastric cancer, to be effective in control of cancer cells in the abdominal peritoneum after the transfer and dissemination, so that patients with advanced gastric cancer in the three-year survival rate from 22 percent to 76 percent, and non-toxic reaction And complications, easy to solve the chemotherapy drugs in the abdominal cavity of the absorption, release of toxic side effects and problems. Using this method to more than 50 cases of advanced gastric cancer patients with the treatment, 3-year survival rate was 76 percent, expected 5-year survival rate up to 50 percent.
This achievement has been related to domestic experts, reached the international advanced level.
